Dow Jones Top Company Headlines at 11 PM ET: Yaccarino's Break From Musk Was Months in the Making | How …

view original post

Yaccarino’s Break From Musk Was Months in the Making

As chief executive of Elon Musk’s X, Linda Yaccarino navigated two turbulent years of charm offensives and legal threats to stabilize a bruised business-just in time for Musk’s merger of X with xAI.

—-

How Volkswagen’s Electric Bus Went From American Flagship to Flop

The German company’s hyped reboot of its iconic vintage van has been stunted by a luxury price tag, Trump’s trade war and an embarrassing recall.

—-

Tesla Shareholders Press Board to Schedule Annual Meeting

Under Texas law, companies are required to hold annual meetings every 13 months.

—-

Ford, GM Earnings Are Coming. Uncertainty Is Still Ridiculously High.

GM reports second quarter earnings July 22. Tesla reports second quarter earnings July 23. Ford reports second quarter earnings July 30.

—-

Amazon’s Prime Day Starts Strong but the Game Is Long

U.S. retailers drove nearly $8 billion in online sales on Tuesday-the biggest e-commerce day so far in 2025. Prime Day has expanded to four days.

—-

Delta’s Earnings Land Thursday. It Looks Like a ‘Lost Year’ for Airline Stocks.

The carrier will report earnings Thursday, providing an update on the health of the travel sector and the U.S. economy.

—-

Ferrero Nears Deal to Acquire Maker of Froot Loops, Frosted Flakes Cereals

A deal for cereal maker WK Kellogg could be finalized as soon as this week.

—-

How Nvidia Became the World’s First $4 Trillion Company

The chip maker at the beating heart of the AI boom is embedded in gaming, data centers and crypto mining.

—-

Stadium Developer CEO Charged With Bid-Rigging Over New Texas Arena

Timothy Leiweke was indicted over allegations that he convinced a rival firm not to compete on the project.

—-

Angeles Equity Partners and Kain Capital Merge Occupational Health Companies

Each private-equity firm will own half of the new combined company, which mainly operates in California.

—-

Merck to Buy Verona Pharma in $10 Billion Deal

The move bolsters Merck’s lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

—-

Prosecutors Question Doctors About UnitedHealth’s Medicare Billing Practices

Justice Department prosecutors recently interviewed former employees about company practices that boost federal payments.


(END) Dow Jones Newswires

July 09, 2025 23:15 ET (03:15 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.